Literature DB >> 11688571

Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.

M Miettinen1, M Furlong, M Sarlomo-Rikala, A Burke, L H Sobin, J Lasota.   

Abstract

Gastrointestinal stromal tumors (GISTs), the specific KIT-positive mesenchymal tumors of the gastrointestinal tract, have been sporadically reported in the rectum, but there are few clinicopathologic series. In this study we analyzed the clinicopathologic features of 133 anorectal GISTs, 3 intramural leiomyomas (LMs), and 8 leiomyosarcomas (LMSs) from the files of the Armed Forces Institute of Pathology and the Haartman Institute of the University of Helsinki. Ninety-six GISTs were documented as KIT-positive and three additional ones as CD34-positive. Thirty-four tumors were included by their histologic similarity to KIT- or CD34-positive cases. GIST-specific c-kit gene mutations, mostly in exon 11, were documented in 18 of 29 cases (62%). The GISTs occurred in adults with the age range of 17-90 years (median 60 years) with a significant male predominance (71%). The tumors ranged from small asymptomatic intramural nodules to large masses that bulged into pelvis causing pain, rectal bleeding, or obstruction. They were mostly highly cellular spindle cell tumors; four tumors had an epithelioid morphology. The tumors coexpressed CD34 and KIT and were rarely positive for smooth muscle actin or desmin and never for S-100 protein. Seventy percent of patients with tumors >5 cm with more than 5 mitoses/50 high power fields (HPF) (n = 31) died of disease, whereas only one tumor <2 cm with <5 mitoses/50 HPF (n = 21) recurred and none caused death. Long latency was common between primary operation and recurrences and metastases; either one occurred in 60 of 111 patients with follow-up (54%). Distant metastases were in the liver, bones, and lungs. Three benign actin- and desmin-positive and KIT-negative intramural LMs, similar to those seen in the esophagus, were identified. There were eight LMSs, six of which formed a polypoid intraluminal mass and were actin-positive and KIT-negative. Despite high mitotic counts, only one LMS patient died of disease. A great majority of rectal smooth muscle and stromal tumors are GISTs, which have a spectrum from minimal indolent tumors to overt sarcomas. Intramural LMs are exceptional, and true LMSs are rare, and similar to colonic ones, often present as intraluminal polypoid masses that appear to have a better prognosis than GISTs with similar mitotic rates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11688571     DOI: 10.1097/00000478-200109000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  122 in total

1.  A large cystic gastrointestinal stromal tumor of the rectum in the retrorectal space.

Authors:  Ryo Takahashi; Satoshi Nagayama; Yukiko Mori; Hiroyoshi Isoda; Akihiko Yoshizawa; Toshiaki Manabe; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2010-05-11       Impact factor: 3.402

2.  Gigantic gastrointestinal stromal tumor in the pelvis.

Authors:  Yasushi Adachi; Hiroyuki Yamamoto; Katsuhiko Nosho; Akiko Tanimura; Hiroo Yuasa; Yoshifumi Ishi; Kohzoh Imai; Yasuo Kato
Journal:  Int J Colorectal Dis       Date:  2004-08-26       Impact factor: 2.571

3.  Gastrointestinal stromal tumor of stomach with inguinal lymph nodes metastasis: a case report.

Authors:  Qin Zhang; Ji-Wei Yu; Wei-Li Yang; Xiao-Sun Liu; Ji-Ren Yu
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

4.  Real anal leiomyoma: a case report.

Authors:  Jaime Alonso Gómez; Antonio Membrives Obrero; David Martínez Cecilia; Yamileth Rangel Mendoza; Alvaro Arjona Sánchez; Jorge Roldán de la Rúa; Amparo Valverde Martínez; Antonio Galán Cabezas; Sebastián Rufián Peña
Journal:  J Gastrointest Cancer       Date:  2011-03

5.  Huge Gastrointestinal Stromal Tumor of the Jejunum Presenting as Bowel Obstruction: A Rare Presentation.

Authors:  Tanweerul Huda; Mahendra Pratap Singh
Journal:  Gastrointest Tumors       Date:  2019-08-20

6.  Estrogen and progesterone receptors expression in gastrointestinal stromal tumors and intramural gastrointestinal leiomyomas.

Authors:  Sergey V Brodsky; Cecilia Gimenez; Chandrani Ghosh; Myron Melamed; Gita Ramaswamy
Journal:  Int J Gastrointest Cancer       Date:  2006

7.  Partial response to imatinib treatment in a patient with unresectable gastrointestinal stromal tumor: A case report and mini literature review.

Authors:  Xiaolong Wu; Libo Feng; Qing Liu; Dong Xia; Liang Xu
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

Review 8.  [Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives].

Authors:  G Mechtersheimer; T Lehnert; R Penzel; S Joos; G Egerer; H F Otto
Journal:  Pathologe       Date:  2003-03-21       Impact factor: 1.011

9.  Colorectal gastrointestinal stromal tumors: a brief review.

Authors:  Rishindra M Reddy; James W Fleshman
Journal:  Clin Colon Rectal Surg       Date:  2006-05

10.  Soft tissue tumors of the anorectum: rare, complex and misunderstood.

Authors:  Mohammed O Nassif; Nora H Trabulsi; Kelli M Bullard Dunn; Ayoub Nahal; Ari-Nareg Meguerditchian
Journal:  J Gastrointest Oncol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.